Priuska E M, Schacht J
Kresge Hearing Research Institute, Department of Otolaryngology, University of Michigan, Ann Arbor 48109, USA.
Biochem Pharmacol. 1995 Nov 27;50(11):1749-52. doi: 10.1016/0006-2952(95)02160-4.
Participation of free radicals in the adverse renal and cochlear side effects of aminoglycoside antibiotics is controversial. We measured the production of free radicals by gentamicin in vitro through the oxidation of arachidonic acid. Gentamicin alone (0.05 to 10 mM) did not cause lipid peroxidation. However, it dramatically promoted radical formation in the presence of iron salts. Peroxidation was maximal at 1 mM gentamicin plus 0.1 mM Fe(II)/Fe(III) (0.05 mM FeSO4 and FeCl3 each). At these iron concentrations, peroxidation was not significant in the absence of gentamicin. Since chelators can enhance iron-catalyzed oxidations, this finding suggested that gentamicin-dependent radical formation was based upon iron chelation. This hypothesis was tested by measuring the influence of gentamicin on the oxidation of salicylate by Fe-EDTA complexes, a reaction that is inhibited by competing iron chelators. Gentamicin was a concentration-dependent inhibitor. In contrast, concentrations of gentamicin as high as 50 mM did not interfere with iron-independent salicylate oxidation. These results suggest that gentamicin acts as an iron chelator, and that the iron-gentamicin complex is a potent catalyst of free radical formation.
自由基是否参与氨基糖苷类抗生素对肾脏和耳蜗的不良副作用存在争议。我们通过体外花生四烯酸氧化来测定庆大霉素产生自由基的情况。单独使用庆大霉素(0.05至10 mM)不会引起脂质过氧化。然而,在铁盐存在的情况下,它会显著促进自由基的形成。在1 mM庆大霉素加0.1 mM Fe(II)/Fe(III)(各0.05 mM硫酸亚铁和氯化铁)时过氧化作用最大。在这些铁浓度下,若无庆大霉素,过氧化作用不明显。由于螯合剂可增强铁催化的氧化作用,这一发现表明庆大霉素依赖性自由基形成是基于铁螯合作用。通过测量庆大霉素对Fe-EDTA复合物催化的水杨酸氧化反应的影响来验证这一假设,该反应会受到竞争性铁螯合剂的抑制。庆大霉素是一种浓度依赖性抑制剂。相比之下,高达50 mM的庆大霉素浓度不会干扰与铁无关的水杨酸氧化。这些结果表明庆大霉素作为一种铁螯合剂,且铁-庆大霉素复合物是自由基形成的有效催化剂。